{"title":"羊水中的催尿素是一种有用的临床炎症生物标志物,可用于组织学羊膜炎的产前预测诊断:一项回顾性初步研究","authors":"Masamitsu Kurakazu , Daichi Urushiyama , Toyofumi Hirakawa, Fusanori Yotsumoto","doi":"10.1016/j.placenta.2025.05.018","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>This study investigated whether presepsin in the amniotic fluid is a useful inflammatory biomarker for the prenatal predictive diagnose of histologic chorioamnionitis (HC).</div></div><div><h3>Methods</h3><div>This retrospective study included 38 singleton pregnant women who were suspected of having an intrauterine infection. All patients underwent amniocentesis and amniotic fluid levels of presepsin (P-SEP), interleukin-8 (IL-8), and interleukin-6 (IL-6) were measured. Concentrations of P-SEP, IL-8, and IL-6 were evaluated for each stage of Blanc's classifications, and correlations between the concentrations were evaluated. Patients were divided into two groups based on the presence or absence of HC and predictors of HC were assessed using a logistic regression model with a combination of maternal white blood cell count (WBC) and maternal C-reactive protein level (CRP) and P-SEP.</div></div><div><h3>Results</h3><div>The concentrations of P-SEP for Blanc's Stage Ⅱ (<em>p</em> = 0.0219) and Stage Ⅲ (<em>p</em> = 0.0262) were significantly higher than those for Blanc's Stage 0. The concentration of P-SEP correlated significantly with that of IL-8 (<em>p</em> = 0.0001) and IL-6 (<em>p</em> < 0.0001). Multivariable analysis showed that WBC (odds ratio (OR), 1.27; 95 % confidence interval (CI), 1.03–1.68), CRP (OR, 1.13; 95 % CI, 0.87–1.58), and P-SEP (OR, 1.12; 95 % CI, 1.00–1.28) were significant predictors of HC.</div></div><div><h3>Discussion</h3><div>P-SEP can be measured in the amniotic fluid and a combination of maternal biomarkers, and P-SEP can predict HC with high accuracy. Therefore, our data provide relevant information to support the early prenatal detection of HC in patients with a suspected intrauterine infection.</div></div>","PeriodicalId":20203,"journal":{"name":"Placenta","volume":"167 ","pages":"Pages 181-186"},"PeriodicalIF":3.0000,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Presepsin in the amniotic fluid is a useful clinical inflammatory biomarker for the prenatal predictive diagnosis of histologic chorioamnionitis: a retrospective preliminary study\",\"authors\":\"Masamitsu Kurakazu , Daichi Urushiyama , Toyofumi Hirakawa, Fusanori Yotsumoto\",\"doi\":\"10.1016/j.placenta.2025.05.018\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>This study investigated whether presepsin in the amniotic fluid is a useful inflammatory biomarker for the prenatal predictive diagnose of histologic chorioamnionitis (HC).</div></div><div><h3>Methods</h3><div>This retrospective study included 38 singleton pregnant women who were suspected of having an intrauterine infection. All patients underwent amniocentesis and amniotic fluid levels of presepsin (P-SEP), interleukin-8 (IL-8), and interleukin-6 (IL-6) were measured. Concentrations of P-SEP, IL-8, and IL-6 were evaluated for each stage of Blanc's classifications, and correlations between the concentrations were evaluated. Patients were divided into two groups based on the presence or absence of HC and predictors of HC were assessed using a logistic regression model with a combination of maternal white blood cell count (WBC) and maternal C-reactive protein level (CRP) and P-SEP.</div></div><div><h3>Results</h3><div>The concentrations of P-SEP for Blanc's Stage Ⅱ (<em>p</em> = 0.0219) and Stage Ⅲ (<em>p</em> = 0.0262) were significantly higher than those for Blanc's Stage 0. The concentration of P-SEP correlated significantly with that of IL-8 (<em>p</em> = 0.0001) and IL-6 (<em>p</em> < 0.0001). Multivariable analysis showed that WBC (odds ratio (OR), 1.27; 95 % confidence interval (CI), 1.03–1.68), CRP (OR, 1.13; 95 % CI, 0.87–1.58), and P-SEP (OR, 1.12; 95 % CI, 1.00–1.28) were significant predictors of HC.</div></div><div><h3>Discussion</h3><div>P-SEP can be measured in the amniotic fluid and a combination of maternal biomarkers, and P-SEP can predict HC with high accuracy. Therefore, our data provide relevant information to support the early prenatal detection of HC in patients with a suspected intrauterine infection.</div></div>\",\"PeriodicalId\":20203,\"journal\":{\"name\":\"Placenta\",\"volume\":\"167 \",\"pages\":\"Pages 181-186\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-05-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Placenta\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0143400425001729\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"DEVELOPMENTAL BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Placenta","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0143400425001729","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DEVELOPMENTAL BIOLOGY","Score":null,"Total":0}
Presepsin in the amniotic fluid is a useful clinical inflammatory biomarker for the prenatal predictive diagnosis of histologic chorioamnionitis: a retrospective preliminary study
Introduction
This study investigated whether presepsin in the amniotic fluid is a useful inflammatory biomarker for the prenatal predictive diagnose of histologic chorioamnionitis (HC).
Methods
This retrospective study included 38 singleton pregnant women who were suspected of having an intrauterine infection. All patients underwent amniocentesis and amniotic fluid levels of presepsin (P-SEP), interleukin-8 (IL-8), and interleukin-6 (IL-6) were measured. Concentrations of P-SEP, IL-8, and IL-6 were evaluated for each stage of Blanc's classifications, and correlations between the concentrations were evaluated. Patients were divided into two groups based on the presence or absence of HC and predictors of HC were assessed using a logistic regression model with a combination of maternal white blood cell count (WBC) and maternal C-reactive protein level (CRP) and P-SEP.
Results
The concentrations of P-SEP for Blanc's Stage Ⅱ (p = 0.0219) and Stage Ⅲ (p = 0.0262) were significantly higher than those for Blanc's Stage 0. The concentration of P-SEP correlated significantly with that of IL-8 (p = 0.0001) and IL-6 (p < 0.0001). Multivariable analysis showed that WBC (odds ratio (OR), 1.27; 95 % confidence interval (CI), 1.03–1.68), CRP (OR, 1.13; 95 % CI, 0.87–1.58), and P-SEP (OR, 1.12; 95 % CI, 1.00–1.28) were significant predictors of HC.
Discussion
P-SEP can be measured in the amniotic fluid and a combination of maternal biomarkers, and P-SEP can predict HC with high accuracy. Therefore, our data provide relevant information to support the early prenatal detection of HC in patients with a suspected intrauterine infection.
期刊介绍:
Placenta publishes high-quality original articles and invited topical reviews on all aspects of human and animal placentation, and the interactions between the mother, the placenta and fetal development. Topics covered include evolution, development, genetics and epigenetics, stem cells, metabolism, transport, immunology, pathology, pharmacology, cell and molecular biology, and developmental programming. The Editors welcome studies on implantation and the endometrium, comparative placentation, the uterine and umbilical circulations, the relationship between fetal and placental development, clinical aspects of altered placental development or function, the placental membranes, the influence of paternal factors on placental development or function, and the assessment of biomarkers of placental disorders.